LMR Partners’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

LMR Partners’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-165,643	Closed	-$5.6M	–	1349
2021 Q2	$5.6M	Buy	+165,643	New	+$4.22M	0.08%	189

LMR Partners's CNST Position: Q3 2021 in Review

LMR Partners sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 165,643 shares — an estimated $5.6M sold.

LMR Partners first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $5.6M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

LMR Partners reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
LMR Partners sold 165,643 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $5.6M.
LMR Partners first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
LMR Partners's Constellation Pharmaceuticals, Inc. position peaked at $5.6M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on LMR Partners's 13F filing for Q3 2021, filed 15 Nov 2021.